Literature DB >> 17971902

Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer.

Marie-Line Puiffe1, Cécile Le Page, Abdelali Filali-Mouhim, Magdalena Zietarska, Véronique Ouellet, Patricia N Tonin, Mario Chevrette, Diane M Provencher, Anne-Marie Mes-Masson.   

Abstract

At least one third of all cases of epithelial ovarian cancer are associated with the production of ascites, although its effect on tumor cell microenvironment remains poorly understood. This study addresses the effect of the heterologous acellular fraction of ovarian cancer-derived ascites on a cell line (OV-90) derived from the chemotherapy-naïve ovarian cancer patient. Ascites were assayed for their effect on cell invasion, growth, and spheroid formation. When compared to either no serum or 5% serum, ascites fell into one of two categories: stimulatory or inhibitory. RNA from OV-90 cells exposed to selected ascites were arrayed on an Affymetrix HG-U133A GeneChip. A supervised analysis identified a number of differentially expressed genes and quantitative polymerase chain reaction validation based on OV-90 cells exposed to 54 independent ascites demonstrated that stimulatory ascites affected the expression of ISGF3G, TRIB1, MKP1, RGS4, PLEC1, and MOSPD1 genes. In addition, TRIB1 expression was shown to independently correlate with prognosis when its expression was ascertained in an independent set of primary cultures established from ovarian ascites. The data support the validity of the strategy to uncover molecular events that are associated with tumor cell behavior and highlight the impact of ascites on the cellular and molecular parameters of ovarian cancer.

Entities:  

Keywords:  Epithelial ovarian cancer; cell behavior; invasion; molecular profiling; ovarian ascites

Mesh:

Substances:

Year:  2007        PMID: 17971902      PMCID: PMC2040209          DOI: 10.1593/neo.07472

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  38 in total

Review 1.  Ovarian surface epithelium: biology, endocrinology, and pathology.

Authors:  N Auersperg; A S Wong; K C Choi; S K Kang; P C Leung
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

2.  Characterization of four novel epithelial ovarian cancer cell lines.

Authors:  D M Provencher; H Lounis; L Champoux; M Tétrault; E N Manderson; J C Wang; P Eydoux; R Savoie; P N Tonin; A M Mes-Masson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-06       Impact factor: 2.416

3.  Constitutively active mitogen-activated protein kinase kinase MEK1 disrupts morphogenesis and induces an invasive phenotype in Madin-Darby canine kidney epithelial cells.

Authors:  R Montesano; J V Soriano; G Hosseini; M S Pepper; H Schramek
Journal:  Cell Growth Differ       Date:  1999-05

4.  Transforming growth factor-alpha levels in the serum and ascites of patients with advanced epithelial ovarian cancer.

Authors:  A K Saltzman; E M Hartenbach; J R Carter; D N Contreras; L B Twiggs; L F Carson; S Ramakrishnan
Journal:  Gynecol Obstet Invest       Date:  1999       Impact factor: 2.031

Review 5.  Angiogenesis in ovarian cancer.

Authors:  M R Brown; J O Blanchette; E C Kohn
Journal:  Baillieres Best Pract Res Clin Obstet Gynaecol       Date:  2000-12

6.  Regulation of transforming growth factor-beta secretion by human peritoneal mesothelial and ovarian carcinoma cells.

Authors:  B Abendstein; S Stadlmann; C Knabbe; M Buck; E Müller-Holzner; A G Zeimet; C Marth; P Obrist; J Krugmann; F A Offner
Journal:  Cytokine       Date:  2000-07       Impact factor: 3.861

7.  Markedly elevated levels of vascular endothelial growth factor in malignant ascites.

Authors:  B K Zebrowski; W Liu; K Ramirez; Y Akagi; G B Mills; L M Ellis
Journal:  Ann Surg Oncol       Date:  1999-06       Impact factor: 5.344

8.  Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway.

Authors:  X Tan; H Egami; M Abe; F Nozawa; M Hirota; M Ogawa
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

9.  Identification and characterization of regulator of G protein signaling 4 (RGS4) as a novel inhibitor of tubulogenesis: RGS4 inhibits mitogen-activated protein kinases and vascular endothelial growth factor signaling.

Authors:  Allan R Albig; William P Schiemann
Journal:  Mol Biol Cell       Date:  2004-11-17       Impact factor: 4.138

10.  Ascites induces modulation of alpha6beta1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma.

Authors:  N Ahmed; C Riley; K Oliva; G Rice; M Quinn
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

View more
  71 in total

1.  Biochemical composition of malignant ascites determines high aggressiveness of undifferentiated ovarian tumors.

Authors:  Justyna Mikuła-Pietrasik; Paweł Uruski; Sebastian Szubert; Rafał Moszyński; Dariusz Szpurek; Stefan Sajdak; Andrzej Tykarski; Krzysztof Książek
Journal:  Med Oncol       Date:  2016-07-18       Impact factor: 3.064

2.  Initial formation of IGROV1 ovarian cancer multicellular aggregates involves vitronectin.

Authors:  Sabrina Kellouche; Julien Fernandes; Johanne Leroy-Dudal; Olivier Gallet; Soizic Dutoit; Laurent Poulain; Franck Carreiras
Journal:  Tumour Biol       Date:  2010-02-24

Review 3.  Aiming to immune elimination of ovarian cancer stem cells.

Authors:  Jiabo Di; Tjitske Duiveman-de Boer; Carl G Figdor; Ruurd Torensma
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

4.  Role of malignant ascites on human mesothelial cells and their gene expression profiles.

Authors:  Isabelle Matte; Denis Lane; Dimcho Bachvarov; Claudine Rancourt; Alain Piché
Journal:  BMC Cancer       Date:  2014-04-24       Impact factor: 4.430

5.  Comparative Proteomics of Ovarian Cancer Aggregate Formation Reveals an Increased Expression of Calcium-activated Chloride Channel Regulator 1 (CLCA1).

Authors:  Natasha Musrap; Alessandra Tuccitto; George S Karagiannis; Punit Saraon; Ihor Batruch; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2015-05-24       Impact factor: 5.157

6.  Ascites IL-10 Promotes Ovarian Cancer Cell Migration.

Authors:  Denis Lane; Isabelle Matte; Perrine Garde-Granger; Paul Bessette; Alain Piché
Journal:  Cancer Microenviron       Date:  2018-07-23

Review 7.  Beyond chemotherapy: targeted therapies in ovarian cancer.

Authors:  Timothy A Yap; Craig P Carden; Stan B Kaye
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

8.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

Review 9.  Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.

Authors:  Emma Kipps; David S P Tan; Stan B Kaye
Journal:  Nat Rev Cancer       Date:  2013-02-21       Impact factor: 60.716

10.  The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer.

Authors:  Denis Lane; Isabelle Matte; Claudine Rancourt; Alain Piché
Journal:  J Ovarian Res       Date:  2010-01-18       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.